Jordan Glenn, PhD

Starting from his time at Omada Health, he has developed a diverse background in the digital health space where he has used his aging expertise in exercise, nutrition, and behavior change to focus on disease states such as diabetes, cardiovascular disease, and now Alzheimer’s and dementia.As Neurotrack’s Chief Science Officer, Jordan leads the company’s scientific development and validation pipeline, while informing the company's business development/ partnerships. He also holds an academic dual-appointment at the University of Arkansas and has been authored on over 100 scientific publications. He is also the primary investigator on the DC-MARVEL project, which is the first study ever to investigate the effects of fully remote, digital health coaching on Alzheimer’s disease risk.Jordan holds a PhD with specializations in exercise physiology, gerontology, and nutrition from the University of Arkansas.